Kombination der Antimalariamittel Mepacrin und Chloroquin bei therapieresistentem kutanem Lupus erythematodes

[1]  E. Zrenner,et al.  Chloroquin-Retinopathie: durch individuelle Tagesdosis vermeidbar , 2008 .

[2]  C. Herrero,et al.  Uncommon cutaneous manifestations of lupus erythematosus , 1997, Lupus.

[3]  Guidelines,et al.  Guidelines of care for cutaneous lupus erythematosus , 1996 .

[4]  J. Callen,et al.  Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. , 1991, Archives of dermatology.

[5]  G. Plewig,et al.  Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. , 1990, Journal of the American Academy of Dermatology.

[6]  D. Wallace.  The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. , 1989, Seminars in arthritis and rheumatism.

[7]  T. Bieber,et al.  Efficiency of acitretin in the treatment of cutaneous lupus erythematosus. , 1988, Archives of dermatology.

[8]  T. Ruzicka,et al.  Dapsone in the treatment of lupus erythematosus , 1981, The British journal of dermatology.

[9]  F. Page.  Treatment of lupus erythematosus with mepacrine. , 1951, Lancet.

[10]  J. Piette,et al.  Chloroquine-quinacrine association in resistant cutaneous lupus. , 1995, Dermatology.

[11]  J. Saurat,et al.  The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. , 1994, Dermatology.

[12]  G. Goerz,et al.  Depigmentierung bei Lupus erythematodes (LE) : Klinischer Clue zum subakut kutanen Lupus erythematodes (SCLE) , 1994 .